1. Home
  2. VNRX vs KTTA Comparison

VNRX vs KTTA Comparison

Compare VNRX & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$2.42

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.85

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNRX
KTTA
Founded
N/A
2020
Country
United States
United States
Employees
N/A
4
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
18.9M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
VNRX
KTTA
Price
$2.42
$0.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$1.67
$3.00
AVG Volume (30 Days)
1.7M
486.3K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
38.00
N/A
EPS
N/A
N/A
Revenue
$1,727,384.00
N/A
Revenue This Year
$355.66
N/A
Revenue Next Year
$849.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
40.04
N/A
52 Week Low
$0.13
$0.28
52 Week High
$2.89
$2.06

Technical Indicators

Market Signals
Indicator
VNRX
KTTA
Relative Strength Index (RSI) 79.62 63.61
Support Level $0.22 $0.67
Resistance Level $2.89 $0.90
Average True Range (ATR) 0.16 0.06
MACD 0.17 0.02
Stochastic Oscillator 82.83 60.70

Price Performance

Historical Comparison
VNRX
KTTA

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: